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CASE REPORT
Three cases of molecularly confirmed Knobloch syndrome
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ABSTRACT
Background: Knobloch syndrome (OMIM 267750) is a rare autosomal recessive disorder due to genetic
defects in the COL18A1 gene. The triad of high myopia, occipital defect, vitreoretinal degeneration has
been described as pathognomonic for this condition. Patients with Knobloch syndrome have also
extraocular problems as brain and kidney malformations. High genetic and phenotypic variation has
been reported in the affected patients.
Materials and Methods: Here we provide detailed clinical description of 3 individuals with Knobloch
syndrome. Ocular examination and fundus imaging have been performed. Detailed information about
systemic conditions has been provided.
Results: Mutations in COL18A1 were identified in all three patients. Patient 1 had congenital hip
dislocation and patient 2 had renal atrophy, cardiac insufficiency and difficult skin healing.
Conclusions: With this report we add to the clinical and genetic knowledge of this rare condition.
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Knobloch syndrome (OMIM 267750) is a rare autosomal
recessive genetic disorder. It was initially described by
Knobloch and Layer in 1971 in a big family with 5
affected family members. The patients were highly myo-
pic, had vitreoretinal degeneration, retinal detachment and
occipital encephalocele (1). Mutations in COL18A1 cause
Knobloch syndrome (2). The gene is located on the long
arm of chromosome 21. In the eye, Col18a1 is shown to
play a role in the anchoring of the vitreal fibrils to the
inner limiting membrane providing an explanation for the
myopia and the retinal detachment. Mice deficient in
Col18a1 have also delayed the regression of the hyaloid
vasculature during ocular development (3). The triad of
high myopia, retinal detachment and occipital defect is
pathognomonic for Knobloch syndrome. The symptoms
can vary in severity and time of onset. Patients with
Knobloch have also extraocular symptoms. Skull deformi-
ties range from meningoencephalocele to isolated scalp
defect in the occipital region. Brain anomalies including
migration anomalies, developmental delay and epilepsy
have been described (4,5). Other organ anomalies such
as unilateral duplex kidney with bifid ureter, congenital
hydronephrosis and hypermobile joints have been shown
in patients with this syndrome (6).
Here we describe three patients with Knobloch syndrome.
The diagnosis was confirmed molecularly in all three indivi-
duals. These cases help to further understand the genotypic
and phenotypic spectrum of this condition.
Material and methods
Three patients were seen in two University Hospitals in
Belgium. The study is performed according to the tenets of
the Declaration of Helsinki.
Each patient underwent full ophthalmic examination with
age-appropriate methods.
Blood samples were taken from the patients after proper
informed consent. DNA was extracted following standard
procedures. Patient 1 and 2 – Sanger sequencing was per-
formed in the COL18A1 gene.
In Patient 3, clinical exome capture (3,638 genes) was
achieved using the SeqCap EZ Choice XL (NimbleGen,
Madison, WI). Samples were subsequently sequenced in
a paired-end 125 bp run on a HiSeq 1500 instrument
(Illumina, San Diego, CA, USA). Bioinformatics pipeline was
launched by BRIGHTcore (BRIGHTcore, Brussels, Belgium)
and filtering of the variants was accomplished using
Highlander (http://sites.uclouvain.be/highlander). The results
were further confirmed by Sanger sequencing.
Patient 1
The patient was a girl born from non-consanguineous par-
ents. She was referred for ophthalmological examination at
the age of 2 years because of reduced vision. She bumped into
objects and had problems of seeing in the distance.
Cycloplegic refraction revealed high myopia: −14.00/-3.50 at
140° and −17.00/-1.00 at 90° for the right and left eye,
respectively.
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Visual acuity using Key Picture Test was 0.9logmar and
less than 1.3logmar at the right and left eye with the optical
correction. She had horizontal nystagmus. Her eye examina-
tion showed normal anterior segments – no cataract or lens
subluxation was present. The eye fundus showed thin retina
with visible choroidal vessels. A retinal defect was present in
the right macular region (Figure 1a). On the left side, a less
well-demarcated atrophic region was present. The ERG
showed the presence of scotopic and photopic responses, but
severely reduced amplitudes and delayed latencies.
The patient had a congenital occipital mass of 4 cm
with serosanguineous secretion. Transfontanel echography
diagnosed occipital meningoencephalocele (Figure 2a).
Surgical correction was performed at the first day of life.
The patient had a normal postnatal neuromotor
development.
The genetic analysis identified two mutations within the
COL18A1. The patient is a compound heterozygote for





Figure 1. Macular defects. Ocular fundus showing different degrees of macular defect: (a) Irregular macular region in the right fundus and atrophic lesion in the left fundus
in Patient 1 (b) Punched out pseudocoloboma in Patient 2 (c) Pigment epithelium alterations on the right side and macular atrophy on the left side in Patient 3.
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Patient 2
The second patient was a 46y old man born from a consan-
guineous marriage. He complained from a loss of vision and
photophobia. He had low vision since childhood. At examina-
tion – the visual acuities were 1,3 logmar on the right side and
Counting Fingers on the left side. Automatic refraction
showed +2.75/+1.25 at 147 and +2/+1.5 at 74 and the axial
length was 29.17 mm and 28.81 mm for the right and left eye,
respectively. The patient had horizontal nystagmus. The ante-
rior segment showed hypoplastic iris crypts, iris transillumi-
nation, correctopia on the left side and bilateral lens
dislocation. The left lens became luxated at age of 13y and
the right at 43y. The ocular fundus revealed bilateral large
macular pseudocolobomas. The retina was extremely thin
with retinal pigment epithelium and choroidal atrophy
(Figure 1b). The sclera was visible through the thinned
atrophic retina giving a white appearance of the fundus.
In the occipital region, the patient had a small oval area of
alopecia. Computed tomography scanning revealed an occipi-
tal bone abnormality, without the involvement of the
meninges (Figure 2b).
The patient had normal mental development. He had
terminal kidney insufficiency with bilateral renal atrophy for
which dialysis was started. He had chronic cardiac hyperten-
sion, dyslipidemia and sleep apnoea. He had accessory spleen.
The patient had venous insufficiency of the lower limbs. He
had multiple atrophic skin lacerations on the lower limbs
caused by mild trauma and reported slow healing of wounds.
The genetic analysis revealed homozygous frameshift
mutation COL18A1 c.1610del (Pro537Glnfs*16).
Patient 3
The third patient is a 15y old girl of consanguineous parents.
She was followed in the ophthalmology clinic because of high
myopia diagnosed since the age of 9 months. At the age of
15 years, her refraction was: −19D (−4 at 3) and – 20D (−5.75
at 173). Despite the correction, she had reduced vision. Her
best-corrected visual acuities were 0,9 logmar on the right and
left side. Her anterior segment examination showed bilaterally
flat iris with atrophic crypts and normal lenses. The vitreous
was fibrillary. The retina had pigment epithelium alterations
in both macular regions with generalised thinning and visible
choroidal vessels (Figure 1c). She developed retinal detach-
ment macula off at age of 6y in the left eye.
In the occipital region, the patient had an area of a darker
coloured skin as an only anomaly (Figure 2c). Mild dys-
morphic features were present with bilateral epicanthus and
upslanting palpebral fissures. She had congenital hip subluxa-
tion. The patient had delayed language development and had
learning difficulties. The motor development was normal.
The axial length of the right eye was 26.89 mm. The
measurements of the left eye failed due to bad fixation.
Genetic analysis identified a homozygous mutation in
COL18A1 c.4492 del G (p. Glu1498Lys*fs). Parental testing
showed that both parents are heterozygous carriers.
Discussion
We present the clinical details of three molecularly proven
patients with Knobloch syndrome. In all three patients, bial-
lelic mutations have been identified within the COL18A1
gene. All mutations are novel and lead to frameshift.
All patients had severe myopia with the low vision below
0.9 logmar despite the optical correction. The ocular fundus
showed abnormalities within the macular region ranging from
pigment epithelial alterations to a macular pseudocoloboma.
Two of the patients developed complications – patient 2 had
lens luxation in both eyes and patient 3 had a retinal detach-
ment in the left eye. These complications lead to further
deterioration of the vision.
In all patients, occipital changes have been noticed. Only
one had encephalocele. The occipital defects ranged from
alopecic area with bone abnormality (patient 2) to
a pigmented skin spot on the back of the head (patient 3).
Although the occipital skull defect was described in the clas-
sical triad, reports have shown that it is not obligatory for the
diagnosis of the syndrome (7). We further show that these
defects can be very mild.
Patient 2 had important extraocular anomalies – kidney
atrophy, accessory spleen and showed delayed skin cicatrisa-
tion. The end-stage renal disease in a relatively young age
a b c
Figure 2. Occipital defects. (a) Ultrasound image, an arrow indicating the communication between the occipital defect and the meningocele cavity in Patient 1 (b)
Cerebral CT showing the occipital bone defect in Patient 2 (c) Pigmented lesion in the occipital area in Patient 3.
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could be related to the mutation in COL18A1, since at least in
the col18a1 knockout mice there are ultrastructural changes in
the kidney (8) which might lead to altered renal function and
stress tolerance predisposing to renal insufficiency. In addi-
tion, Col18a1 knockout mice have elevated creatinine levels
(9) which also indicates that Col18a1 affects renal filtration
and function. However, terminal end-stage renal disease and
renal atrophy related to renal insufficiency can be secondary
to the elevated blood pressure, vascular defects or diabetes.
Another observation is the difficult skin healing which can be
related to the COL18A1 insufficiency. The COL18A1 gene is
expressed in the skin (10) and takes part in the basal mem-
brane. The role of COL18A1 in modulating the wound heal-
ing has been shown by Seppinen et al. (11). The authors
conclude that the lack of Col18a1 accelerates wound healing
while the overexpression of the endostatin domain leads to
delayed healing in mice. However, in oral mucosa, the lack of
Col18a1 leads to a dramatic decrease in the markers of kera-
tinisation (12). In addition, Maeba et al. recently showed that
COL18A1 has a role in the dermal-epidermal junction during
wound healing (13). The genetic defect in patient 2 leads to
loss of function of COL18A1 including the endostatin iso-
form. Possibly this causes delayed epithelialisation. Again,
this has to be further investigated since systemic (hyperten-
sion, dyslipidemia, kidney insufficiency) and local (venous
insufficiency in lower limbs) factors affect wound healing as
well. Accessory spleen is present in 11% in the normal popu-
lation and its link with the syndrome is not certain (14). The
mental development of the patients ranged from normal to
learning difficulties. None of the patients had epilepsy or
severe mental problems.
Knobloch syndrome has clinical overlap with other con-
nective tissue disorders as Stickler (OMIM 609508), Weill –
Marchesani (OMIM 608328) and Marfan (OMIM 154700)
syndromes. Patients with these syndromes also have high
myopia, risk for retinal detachment and lens subluxation
(15,16,17). In comparison with patients affected with
Knobloch syndrome who typically have macular defects and
early onset macular dystrophy, the patients with Stickler and
Marfan often have better vision in childhood unless compli-
cations occur since there is no macular dystrophy. However,
chorioretinal atrophy mainly around the vasculature can
develop also in individuals with Stickler syndrome (16).
Goldmann–Favre (OMIM 268100) and Wagner (OMIM
143200) syndromes similarly to Knobloch are vitreoretinopa-
thies characterized by abnormal vitreous and retinal dystro-
phy. Goldmann–Favre is caused by mutations in NR2E3
encoding a nuclear receptor. While the vitreous in these
patients is abnormal, their refraction most often shows mild
hyperopia in contrast to the Knobloch patients. The retina
shows characteristic heavy pigment clumps outside the
arcades. The ERG is abnormal and pathognomonic with max-
imal scotopic ERG resembling the photopic response (18).
Wagner syndrome is caused by mutations in the VCAN
gene (19). Affected individuals present with optically empty
vitreous with typical vitreal veils. In addition, these patients
have cataracts and often develop a retinal detachment. The
electroretinogram is abnormal with reduced responses con-
firming the retinal dystrophy (20).
With this report, we add to the clinical knowledge of
patients with Knobloch syndrome. Systemic evaluation is
important in the follow-up. Further investigations and case
reports of the systemic conditions in these patients will help to
better understand the spectrum of associated anomalies.
Finally, this syndrome should be considered in the diagnostic
workup of patients with pathological myopia.
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